Philadelphia, PA
On October 14, 2015, Cleary Gottlieb associate Elaine Ewing participated in a panel discussion titled, “Antitrust and Competition Law Considerations –Devising Antitrust Strategies in M&A Transactions and Coordinating Global Reporting Obligations,” as part of the CBI’s Mergers & Acquisitions and Strategic Alliances in Life Sciences conference. CBI, a division of UBM Life Sciences is a leader in conferences for the pharmaceutical industry.
For additional information, please visit the event’s website.